듀켐바이오

176750KOSDAQ

62.8 / 100

Reference Date: 2026-09-08

Financial Score22.5 / 40

News Sentiment21.3 / 25

Momentum9.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PBR raises overvaluation concerns. Declined 5.7% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Dukem Bio is a company specializing in the development, manufacturing, and sales of radiopharmaceuticals for cancer and brain diseases, holding the largest number of PET-CT radiopharmaceutical products in South Korea. In 2025, it achieved revenue of 38.57 billion won and operating profit of 7.44 billion won, maintaining a market share leadership in key product lines such as FDG and Alzheimer's diagnostic agents. By acquiring RadioDnS Labs in 2024, the company is enhancing its R&D capabilities and aiming to become a global leader in radiopharmaceuticals.

Number of Employees

144people

Average Salary

44.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

27.25Industry Average 15.001.5Point

1.8x industry avg (risky)

PBR

3.61Industry Average 1.200.0Point

3.0x industry avg (risky)

ROE

14.05Industry Average 8.005.5Point

1.8x industry avg (good)

Debt Ratio

20.42Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2024~20257.5 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲8.3% (1-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲46.6% (1-year basis)

ROE Trend

2.5 / 4

Avg ROE 19.4% (declining, 2yr)

Detailed News Sentiment

9 totalPositive 9Neutral 0Negative 0Average Sentiment Score 85

Positive
듀켐바이오, '방사성의약품 CDMO 공장' 짓는다
듀켐바이오가 방사성의약품 CDMO 공장 건설을 위한 대규모 투자 협약을 체결하여 기술적 우위와 시장 확장 기회를 확보했다.
Positive
방사성의약품 1위 기업 듀켐바이오 정읍에 둥지…343억 투자
듀켐바이오의 정읍 신규 투자로 연구 인프라 강화 및 신제품 개발 가속화 기대.
Positive
듀켐바이오, 정읍에 343억원 규모 투자…전북도 등과 협약
듀켐바이오의 대규모 투자로 정읍에 방사성의약품 생산시설 및 R&D 센터 구축이 확정되어 기업 성장과 지역 경제 활성화 기대.

Detailed Momentum

52-week position1.0Point

Near 52w low (12%, downtrend)

Current 6,240Won52-week high 11,68052-week low 5,440

1-month return2.0Point

1m -5.74% (slight drop)

Volume trend6.0Point

Volume increasing

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0

Neutral신규시설투자등2026-09-04
Neutral주식등의대량보유상황보고서(약식)2026-08-31
Neutral주식등의대량보유상황보고서(약식)2026-08-31
Neutral반기보고서 (2026.06)2026-08-14